Q

Qiagen NV
D

QGEN

40.360
USD
0.33
(0.81%)
مغلق
حجم التداول
128,999
الربح لكل سهم
2
العائد الربحي
-
P/E
106
حجم السوق
8,722,445,877
أصول ذات صلة
NEOUSD
NEOUSD
0.09191
(2.00%)
4.69523 USD
BDX
BDX
-4.810
(-2.12%)
221.585 USD
C
CRL
-8.420
(-5.64%)
140.940 USD
DGX
DGX
2.710
(1.61%)
170.620 USD
GILD
GILD
0.450
(0.40%)
112.380 USD
HOLX
HOLX
1.130
(1.87%)
61.680 USD
IQV
IQV
-6.775
(-3.89%)
167.590 USD
LH
LH
-3.020
(-1.28%)
233.360 USD
N
NEO
-0.67000
(-7.12%)
8.74000 USD
TMO
TMO
-18.94
(-3.87%)
470.10 USD
المزيد
الأخبار المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).